These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26390708)

  • 1. Bilateral salpingo-oophorectomy and adhesiolysis with single port access laparoscopy and use of diode laser in a BRCA carrier.
    Angioni S; Pontis A; Sorrentino F; Nappi L
    Eur J Gynaecol Oncol; 2015; 36(4):479-81. PubMed ID: 26390708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.
    Holman LL; Friedman S; Daniels MS; Sun CC; Lu KH
    Gynecol Oncol; 2014 May; 133(2):283-6. PubMed ID: 24582866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers.
    Perabò M; Fink V; Günthner-Biller M; von Bodungen V; Friese K; Dian D
    Arch Gynecol Obstet; 2014 Jun; 289(6):1325-30. PubMed ID: 24389920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
    Kwon JS; Tinker A; Pansegrau G; McAlpine J; Housty M; McCullum M; Gilks CB
    Obstet Gynecol; 2013 Jan; 121(1):14-24. PubMed ID: 23232752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
    Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
    Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
    BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure natural orifice transluminal endoscopic surgery (NOTES) involving peroral endoscopic salpingo-oophorectomy (POESY).
    Hornemann A; Suetterlin M; Trunk MJ; Gerhardt A; Kaehler G
    Int J Gynaecol Obstet; 2014 Apr; 125(1):86-8. PubMed ID: 24434232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) for prophylactic bilateral salpingo-oophorectomy.
    Goldenberg M; Burke YZ; Matanes E; Lowenstein L
    Surg Oncol; 2020 Dec; 35():79-80. PubMed ID: 32846269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
    Nebgen DR; Hurteau J; Holman LL; Bradford A; Munsell MF; Soletsky BR; Sun CC; Chisholm GB; Lu KH
    Gynecol Oncol; 2018 Jul; 150(1):79-84. PubMed ID: 29735278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.
    Powell CB; Chen LM; McLennan J; Crawford B; Zaloudek C; Rabban JT; Moore DH; Ziegler J
    Int J Gynecol Cancer; 2011 Jul; 21(5):846-51. PubMed ID: 21670699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis.
    Chene G; Rahimi K; Mes-Masson AM; Provencher D
    J Minim Invasive Gynecol; 2013; 20(2):153-9. PubMed ID: 23332575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of peritoneal lavage cytology during laparoscopic salpingo-oophorectomy: a retrospective analysis.
    Haldar K; Giamougiannis P; Crawford R
    BJOG; 2011 Jan; 118(1):28-33. PubMed ID: 21054763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-port versus conventional multiport access prophylactic laparoscopic bilateral salpingo-oophorectomy in high-risk patients for ovarian cancer: a comparison of surgical outcomes.
    Angioni S; Pontis A; Sedda F; Zampetoglou T; Cela V; Mereu L; Litta P
    Onco Targets Ther; 2015; 8():1575-80. PubMed ID: 26170692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serous tubal intraepithelial carcinoma arising from the intrauterine portion of the fallopian tube after bilateral salpingo-oophorectomy.
    Yoshida H; Shintani D; Imai Y; Fujiwara K
    Eur J Gynaecol Oncol; 2016; 37(3):404-6. PubMed ID: 27352575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
    Harmsen MG; Arts-de Jong M; Hoogerbrugge N; Maas AH; Prins JB; Bulten J; Teerenstra S; Adang EM; Piek JM; van Doorn HC; van Beurden M; Mourits MJ; Zweemer RP; Gaarenstroom KN; Slangen BF; Vos MC; van Lonkhuijzen LR; Massuger LF; Hermens RP; de Hullu JA
    BMC Cancer; 2015 Aug; 15():593. PubMed ID: 26286255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.
    Arts-de Jong M; Harmsen MG; Hoogerbrugge N; Massuger LF; Hermens RP; de Hullu JA
    Gynecol Oncol; 2015 Feb; 136(2):305-10. PubMed ID: 25560807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review.
    Finch A; Narod SA
    Maturitas; 2011 Nov; 70(3):261-5. PubMed ID: 21893388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
    Olivier RI; van Beurden M; Lubsen MA; Rookus MA; Mooij TM; van de Vijver MJ; van't Veer LJ
    Br J Cancer; 2004 Apr; 90(8):1492-7. PubMed ID: 15083174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Single-port surgery and adnexal procedures: which indications in oncological surgery?].
    Heinemann M; Hamouda S; Petrovic M; Jauffret C; Canone F; Chéreau-Ewald E; Buttarelli M; Houvenaeghel G; Lambaudie E
    Gynecol Obstet Fertil; 2013; 41(7-8):421-6. PubMed ID: 23876419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.